FTC settles with supplement startup over COVID claims

A multi-year case involving dietary supplement startup PPO Lab, the Federal Trade Commission (FTC) and COVID-19-related health claims has come to a close, culminating in a truce that removes fines and lightens administrative burdens on the defendants.

Related Keywords

California ,United States ,Asa Waldstein ,John Vecchione ,Casey Norman ,Samuel Levine ,Bureau Of Consumer Protection ,Precision Patient Outcomes Inc ,Civil Liberties Alliance ,Drug Administration ,Advisory Group ,New Civil Liberties Alliance ,Priest Lewis ,Federal Trade Commission ,Patient Outcomes ,Margrett Priest Lewis ,Consumer Protection ,Supplement Advisory Group ,Regulation ,Manufacturers ,Coronavirus ,Regulations ,Egislation Amp Enforcement ,Product Claims ,Immune Support ,Minerals ,Olyphenols ,Covid 19 Claims ,Startup ,